Rishabh Jain

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Placebo Controlled

Top Venues

JMIR research protocols

This page only lists publications with an associated author ORCID identifier.

Publications

Rishabh Jain, Akash Jha, Vinod Sharma, Ranjit Kumar Sahoo, Aparna Sharma, Amlesh Seth, Brusabhanu Nayak, Shamim Ahmed Shamim, Seema Kaushal, Haresh Kp, Chandan J Das, Atul Batra
Carboplatin in Patients With Metastatic Castration-Resistant Prostate Cancer Harboring Somatic or Germline Homologous Recombination Repair Gene Mutations: Phase II Single-Arm Trial. JMIR research protocols 13 (2024)
Rishabh Jain, Akash Jha, Vinod Sharma, Ranjit Kumar Sahoo, Aparna Sharma, Amlesh Seth, Brusabhanu Nayak, Shamim Ahmed Shamim, Seema Kaushal, Haresh Kp, Chandan J Das, Atul Batra
Carboplatin in Patients With Metastatic Castration-Resistant Prostate Cancer Harboring Somatic or Germline Homologous Recombination Repair Gene Mutations: Phase II Single-Arm Trial. JMIR research protocols 13 (2024)
Rishabh Jain, Akash Jha, Vinod Sharma, Ranjit Kumar Sahoo, Aparna Sharma, Amlesh Seth, Brusabhanu Nayak, Shamim Ahmed Shamim, Seema Kaushal, Haresh Kp, Chandan J Das, Atul Batra
Carboplatin in Patients With Metastatic Castration-Resistant Prostate Cancer Harboring Somatic or Germline Homologous Recombination Repair Gene Mutations: Phase II Single-Arm Trial. JMIR research protocols 13 (2024)
Rishabh Jain, Akash Jha, Vinod Sharma, Ranjit Kumar Sahoo, Aparna Sharma, Amlesh Seth, Brusabhanu Nayak, Shamim Ahmed Shamim, Seema Kaushal, Haresh Kp, Chandan J Das, Atul Batra
Carboplatin in Patients With Metastatic Castration-Resistant Prostate Cancer Harboring Somatic or Germline Homologous Recombination Repair Gene Mutations: Phase II Single-Arm Trial. JMIR research protocols 13 (2024)